Celltrion Bags FDA Approval For High-Concentration Humira Rival

Yuflyma, Ninth US Adalimumab Biosimilar, Will Be Marketed Directly By Korean Firm

 
• By David Wallace
  
Red 100 emoji
Celltrion has obtained approval for a 100mg/ml adalimumab biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products